| Nome |
# |
|
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease, file dfa8b990-7caa-748b-e053-3a05fe0a3a96
|
949
|
|
Early maternal deprivation immunologically primes hippocampal synapses by redistributing interleukin-1 receptor type I in a sex dependent manner, file dfa8b990-ceca-748b-e053-3a05fe0a3a96
|
835
|
|
Effect of rasagiline on the molecular composition of the excitatory postsynaptic density, file dfa8b98f-6a65-748b-e053-3a05fe0a3a96
|
632
|
|
Leukotriene D(4)-induced activation of smooth-muscle cells from human bronchi is partly Ca(2+)-independent, file dfa8b98f-c51e-748b-e053-3a05fe0a3a96
|
621
|
|
SAP97-mediated local trafficking is altered in Alzheimer disease patients' hippocampus, file dfa8b990-8481-748b-e053-3a05fe0a3a96
|
505
|
|
SNAP-25 regulates spine formation through postsynaptic binding to p140Cap, file dfa8b993-e356-748b-e053-3a05fe0a3a96
|
369
|
|
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure., file dfa8b9a0-4053-748b-e053-3a05fe0a3a96
|
325
|
|
Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases, file dfa8b990-7490-748b-e053-3a05fe0a3a96
|
298
|
|
Modeling Alzheimer's disease: from past to future, file dfa8b991-3c36-748b-e053-3a05fe0a3a96
|
249
|
|
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker, file dfa8b99d-de96-748b-e053-3a05fe0a3a96
|
234
|
|
Latent profile analysis in frontotemporal lobar degeneration and related disorders : clinical presentation and SPECT functional correlates, file dfa8b98f-2bdf-748b-e053-3a05fe0a3a96
|
206
|
|
N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons, file dfa8b990-7c11-748b-e053-3a05fe0a3a96
|
203
|
|
Amyloid-β oligomers regulate ADAM10 synaptic localization through aberrant plasticity phenomena, file dfa8b99e-0441-748b-e053-3a05fe0a3a96
|
190
|
|
Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors, file dfa8b990-4132-748b-e053-3a05fe0a3a96
|
189
|
|
Coxsackievirus adenovirus receptor loss impairs adult neurogenesis, synapse content, and hippocampus plasticity, file dfa8b996-7e6f-748b-e053-3a05fe0a3a96
|
189
|
|
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration, file dfa8b990-8611-748b-e053-3a05fe0a3a96
|
187
|
|
Rabphilin 3A : a novel target for the treatment of levodopa-induced dyskinesias, file dfa8b99a-3d03-748b-e053-3a05fe0a3a96
|
169
|
|
Biological, neuroimaging, and neurophysiological markers in frontotemporal dementia : three faces of the same coin, file dfa8b999-e0bb-748b-e053-3a05fe0a3a96
|
168
|
|
Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons, file dfa8b991-08fa-748b-e053-3a05fe0a3a96
|
167
|
|
Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation, file dfa8b98f-695b-748b-e053-3a05fe0a3a96
|
162
|
|
Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus, file dfa8b994-fb2d-748b-e053-3a05fe0a3a96
|
157
|
|
NMDA receptor gluN2A/gluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias : from experimental models to patients, file dfa8b993-0729-748b-e053-3a05fe0a3a96
|
156
|
|
Protein-protein interactions at the {NMDA} receptor complex: From synaptic retention to synaptonuclear protein messengers, file dfa8b9a7-34d4-748b-e053-3a05fe0a3a96
|
151
|
|
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex, file dfa8b994-0b8e-748b-e053-3a05fe0a3a96
|
130
|
|
SAP97-mediated ADAM10 trafficking from Golgi outposts depends on PKC phosphorylation, file dfa8b991-dfa7-748b-e053-3a05fe0a3a96
|
128
|
|
Toward a Glutamate Hypothesis of Frontotemporal Dementia, file dfa8b99d-e436-748b-e053-3a05fe0a3a96
|
118
|
|
LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias, file dfa8b995-f23a-748b-e053-3a05fe0a3a96
|
114
|
|
Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition, file dfa8b99f-613d-748b-e053-3a05fe0a3a96
|
114
|
|
NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features, file dfa8b9a5-5638-748b-e053-3a05fe0a3a96
|
111
|
|
Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target, file dfa8b999-ec0f-748b-e053-3a05fe0a3a96
|
106
|
|
Loss of Ryanodine Receptor 2 impairs neuronal activity-dependent remodeling of dendritic spines and triggers compensatory neuronal hyperexcitability, file dfa8b9a3-7b96-748b-e053-3a05fe0a3a96
|
106
|
|
Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target, file dfa8b99a-1f0d-748b-e053-3a05fe0a3a96
|
100
|
|
A light-gated potassium channel for sustained neuronal inhibition, file dfa8b99c-c95e-748b-e053-3a05fe0a3a96
|
96
|
|
AlphaCaMKII and NMDA-receptor subunit expression in epileptogenic cortex from human periventricular nodular heterotopia, file dfa8b990-7a62-748b-e053-3a05fe0a3a96
|
95
|
|
Cyclase-associated protein 2 dimerization regulates cofilin in synaptic plasticity and Alzheimer's disease, file dfa8b9a4-b467-748b-e053-3a05fe0a3a96
|
87
|
|
Adam10 plasma and csf levels are increased in mild Alzheimer’s disease, file dfa8b9a6-a396-748b-e053-3a05fe0a3a96
|
83
|
|
Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice, file dfa8b98f-2be3-748b-e053-3a05fe0a3a96
|
81
|
|
Proximity ligation assay reveals both pre- A nd postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain, file dfa8b9a2-35f9-748b-e053-3a05fe0a3a96
|
75
|
|
Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity, file dfa8b9a1-f213-748b-e053-3a05fe0a3a96
|
73
|
|
GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice, file dfa8b9a7-b9b2-748b-e053-3a05fe0a3a96
|
73
|
|
Looking at Alzheimer’s disease pathogenesis from the nuclear side, file dfa8b9a9-68ed-748b-e053-3a05fe0a3a96
|
67
|
|
Dysregulated ADAM10-mediated processing of APP during a critical time window leads to Synaptic Deficits in Fragile X syndrome, file dfa8b992-c852-748b-e053-3a05fe0a3a96
|
64
|
|
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease, file f525a913-e257-451c-ac98-c02dc0253ac9
|
55
|
|
Role of glycogen synthase kinase-3β in APP hyperphosphorylation induced by NMDA stimulation in cortical neurons, file dfa8b99a-fb49-748b-e053-3a05fe0a3a96
|
46
|
|
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies, file f8d32011-d2fc-40e1-a114-1492b3a691d1
|
35
|
|
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease, file dfa8b9aa-6360-748b-e053-3a05fe0a3a96
|
19
|
|
GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice, file 6c720bd5-f9ad-4c10-a2a5-50e951eac132
|
14
|
|
Biological, neuroimaging, and neurophysiological markers in frontotemporal dementia : three faces of the same coin, file dfa8b99a-c6f1-748b-e053-3a05fe0a3a96
|
14
|
|
Rabphilin-3A Drives Structural Modifications of Dendritic Spines Induced by Long-Term Potentiation, file ce6847ea-9b08-4d7f-a33e-2a55a5d10636
|
13
|
|
The Synaptonuclear Messenger RNF10 Acts as an Architect of Neuronal Morphology, file dfa8b99f-a398-748b-e053-3a05fe0a3a96
|
12
|
|
The Synaptonuclear Messenger RNF10 Acts as an Architect of Neuronal Morphology, file 38b90f05-c213-4f85-bcbc-be09e4dd0fb9
|
11
|
|
Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis, file dfa8b9aa-7aeb-748b-e053-3a05fe0a3a96
|
11
|
|
Amyloid-β oligomers regulate ADAM10 synaptic localization through aberrant plasticity phenomena, file 57f65534-4866-4e72-85fe-8bdc9066d0a2
|
9
|
|
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients, file dfa8b9aa-736e-748b-e053-3a05fe0a3a96
|
9
|
|
Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses, file 71f7356b-24f8-4525-a2a0-8d26c5a60337
|
7
|
|
The soluble extracellular fragment of neuroligin-1 targets Aβ oligomers to the postsynaptic region of excitatory synapses, file dfa8b994-cb59-748b-e053-3a05fe0a3a96
|
6
|
|
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects, file dfa8b995-0863-748b-e053-3a05fe0a3a96
|
6
|
|
The MULTI-ACT model: the path forward for participatory and anticipatory governance in health research and care, file dfa8b9aa-7431-748b-e053-3a05fe0a3a96
|
5
|
|
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19, file ece05b32-3348-4287-8604-e448479b707b
|
5
|
|
Reciprocal cortico-amygdala connections regulate prosocial and selfish choices in mice, file 64c9fbde-b3c5-401c-9421-377081fa6126
|
4
|
|
Functional and molecular cross-talk between Dopamine and NMDA receptors in striatum, file dfa8b98f-7896-748b-e053-3a05fe0a3a96
|
4
|
|
Alzheimer's disease and modern lifestyle : what is the role of stress?, file dfa8b994-a270-748b-e053-3a05fe0a3a96
|
4
|
|
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease, file dfa8b99a-d075-748b-e053-3a05fe0a3a96
|
4
|
|
Dissecting social decision-making: A spotlight on oxytocinergic transmission, file 5e069fe0-92ff-476f-abfe-c3afbbafc76a
|
3
|
|
Amyloid-β oligomers regulate ADAM10 synaptic localization through aberrant plasticity phenomena, file 94630b89-8648-4c24-a16b-d939ce118c7d
|
3
|
|
Loss of Ryanodine Receptor 2 impairs neuronal activity-dependent remodeling of dendritic spines and triggers compensatory neuronal hyperexcitability, file 9775e450-f364-4f39-8cea-d1b2bfd3a537
|
2
|
|
Consensus Statement on European Brain Research : The need to expand brain research in Europe - 2015, file dfa8b995-f244-748b-e053-3a05fe0a3a96
|
2
|
|
ADAM10 as a therapeutic target for brain diseases : from developmental disorders to Alzheimer's disease, file dfa8b999-ec7d-748b-e053-3a05fe0a3a96
|
2
|
|
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease, file dfa8b99b-b109-748b-e053-3a05fe0a3a96
|
2
|
|
Differential mechanisms of tolerance induced by NMDA and 3,5-dihydroxyphenylglycine (DHPG) preconditioning, file dfa8b9a4-fbf5-748b-e053-3a05fe0a3a96
|
2
|
|
Synaptic neurofilaments and GluN1-NfL interaction in experimental models of α-synucleinopathies, file 91d470e1-e856-4161-839b-1412573a4079
|
1
|
|
The voice of the next generation, file dfa8b994-e006-748b-e053-3a05fe0a3a96
|
1
|
|
The Hitchhiker's Guide to a Neuroscience Career, file dfa8b994-fce3-748b-e053-3a05fe0a3a96
|
1
|
|
Introduction to the 2016 Consensus Document on European Brain Research, file dfa8b995-d8f3-748b-e053-3a05fe0a3a96
|
1
|
|
Synapse-to-nucleus communication: from developmental disorders to Alzheimer's disease, file dfa8b99a-25ba-748b-e053-3a05fe0a3a96
|
1
|
|
MicroRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease, file dfa8b99a-3e19-748b-e053-3a05fe0a3a96
|
1
|
|
The effect of APOE genotype on clinical phenotype in Alzheimer disease, file dfa8b99c-2026-748b-e053-3a05fe0a3a96
|
1
|
|
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology, file dfa8b99c-25ad-748b-e053-3a05fe0a3a96
|
1
|
|
The Synaptonuclear Messenger RNF10 Acts as an Architect of Neuronal Morphology, file dfa8b99f-e335-748b-e053-3a05fe0a3a96
|
1
|
|
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure., file dfa8b9a1-1b19-748b-e053-3a05fe0a3a96
|
1
|
|
Farmaci nella terapia della demenza di Alzheimer, file dfa8b9a3-f083-748b-e053-3a05fe0a3a96
|
1
|
|
Farmaci per il sistema nervoso centrale, file dfa8b9a4-208f-748b-e053-3a05fe0a3a96
|
1
|
|
Synaptic dysfunction in early phases of Alzheimer's Disease, file dfa8b9a9-1958-748b-e053-3a05fe0a3a96
|
1
|
|
Novel therapeutic approaches to target neurodegeneration, file e3f98853-209e-4637-bdab-cf79db931539
|
1
|
| Totale |
9455 |